ADMA Biologics Competitors and Similar CompaniesClear all
CorMedix's competitors and similar companies include Autolus.
 CorMedix CorMedix is a pharmaceutical company that seeks to in-license, develop and commercialize therapeutic products for the treatment of cardiac and kidney disease. |  Autolus Autolus Therapeutics is a private biopharmaceutical company, focused on the development and commercialization of engineered T-cell immunotherapy products. | |
Founding Date | Founding Date 2006 | Founding Date 2014 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Berkeley Heights, US HQ | Locations London, GB HQ London, GB |
Employees | Employees 3036% increase | Employees 647 |
Valuation ($) | Valuation ($) 749.2 m | Valuation ($) 1.2 b |
Financial | ||
Revenue (est.) | Revenue (est.) $311.7m (FY, 2025) | Revenue (est.) $75.4m (FY, 2025) |
Cost of goods | Cost of goods $22.1m (FY, 2025) | Cost of goods $86.6m (FY, 2025) |
Gross profit | Gross profit $275.7m (FY, 2025) | Gross profit ($10.7m) (FY, 2025) |
Net income | Net income $163.1m (FY, 2025) | Net income ($287.5m) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 11.5m | Total funding raised $ 281.7m |
For sources of this data, please see the company profile
View Company Profiles
Autolus
HQ
London, GB
Employees
647
Autolus Therapeutics is a private biopharmaceutical company, focused on the development and commercialization of engineered T-cell immunotherapy products.
View company